Skip to main content

Table 6 Relationships of MIR31HG SNPs with SONFH risk stratified by course and bilateral

From: MIR31HG polymorphisms are related to steroid-induced osteonecrosis of femoral head among Chinese Han population

SNP

Allele/Genotype

Case 1 (course > 29 month)

Case 2 (course ≤29 month)

OR (95% CI)

p

Cases with bilateral

Control

OR (95% CI)

p

rs1332184

G

95

207

1

 

216

746

1

 

A

27

71

0.83 (0.50–1.37)

0.466

70

268

0.90 (0.67–1.22)

0.506

G/G

35

74

1

 

77

276

1

 

G/A

25

59

0.10 (0.53–1.88)

0.987

62

194

1.10 (0.74–1.63)

0.650

A/A

1

6

0.27 (0.03–2.45)

0.246

4

37

0.38 (0.13–1.14)

0.084

G/A-A/A

26

65

0.91 (0.49–1.70)

0.764

66

231

0.98 (0.67–1.45)

0.935

rs72703442

C

106

237

1

 

244

849

1

 

A

16

41

0.87 (0.47–1.62)

0.667

42

165

0.89 (0.61–1.28)

0.517

C/C

45

100

1

 

102

352

1

 

C/A

16

37

0.98 (0.48–1.97)

0.949

40

145

0.93 (0.60–1.43)

0.727

A/A

0

2

/

 

1

10

0.40 (0.05–3.27)

0.393

C/A-A/A

16

39

0.90 (0.45–1.81)

0.767

41

155

0.90 (0.59–1.37)

0.610

rs2025327

T

105

252

1

 

259

892

1

 

C

17

26

1.57 (0.82–3.01)

0.173

27

124

0.75 (0.48–1.16)

0.197

T/T

44

115

1

 

117

391

1

 

T/C

17

22

2.14 (1.01–4.53)

0.046*

25

110

0.70 (0.43–1.16)

0.164

C/C

0

2

/

 

1

7

0.49 (0.06–4.09)

0.506

T/C-C/C

17

24

1.93 (0.92–4.02)

0.081

26

117

0.69 (0.42–1.13)

0.136

rs55683539

C

92

216

1

 

220

767

1

 

T

30

62

1.14 (0.69–1.87)

0.617

66

247

0.93 (0.68–1.27)

0.654

C/C

33

83

1

 

82

297

1

 

C/T

26

50

1.35 (0.71–2.57)

0.355

56

173

1.16 (0.77–1.73)

0.481

T/T

2

6

0.80 (0.15–4.37)

0.796

5

37

0.52 (0.19–1.41)

0.198

C/T-T/T

28

56

1.29 (0.69–2.41)

0.422

61

210

1.05 (0.71–1.55)

0.812

rs2181559

T

75

191

1

 

193

651

1

 

A

45

87

1.37 (0.84–2.06)

0.228

91

365

0.84 (0.64–1.11)

0.225

T/T

22

65

1

 

63

213

1

 

T/A

31

61

1.68 (0.85–3.31)

0.135

67

225

1.04 (0.69–1.56)

0.854

A/A

7

13

1.54 (0.53–4.48)

0.427

12

70

0.53 (0.27–1.07)

0.078

T/A-A/A

38

74

1.65 (0.87–3.15)

0.128

79

295

0.91 (0.62–1.35)

0.640

rs10965059

C

108

251

1

 

257

829

1

 

T

14

27

1.21 (0.61–2.39)

0.592

29

169

0.56 (0.36–0.84)

0.005*

C/C

48

116

1

 

119

340

1

 

C/T

12

19

1.54 (0.68–3.50)

0.301

19

149

0.43 (0.25–0.74)

0.002*

T/T

1

4

0.87 (0.09–8.29)

0.900

5

10

1.55 (0.49–4.89)

0.452

C/T-T/T

13

23

1.45 (0.66–3.16)

0.357

24

159

0.51 (0.31–0.83)

0.007*

rs10965064

C

78

179

1

 

184

640

1

 

G

44

99

1.02 (0.66–1.59)

0.931

102

376

0.94 (0.72–1.24)

0.677

C/C

21

59

1

 

55

203

1

 

C/G

36

61

1.53 (0.79–2.97)

0.212

74

234

1.11 (0.76–1.68)

0.612

G/G

4

19

0.52 (0.15–1.76)

0.290

14

71

0.73 (0.37–1.43)

0.359

C/G-G/G

40

80

1.29 (0.68–2.45)

0.440

88

305

1.03 (0.69–1.53)

0.896

  1. SNP Single nucleotide polymorphism, CI Confidence interval, OR Odds ratio
  2. p values were calculated by logistic regression adjusted by age and gender
  3. *indicates statistical significance (p < 0.05)